Properties
                                        
                            Description
                            CGI1746, soluble in DMSO and warmed ethanol and insoluble in water, is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells.
                         
                                                                            
                                                            
                            Molecular Formula
                            C34H37N5O4
                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                            
                                                                                                                                                                            
                            Solubility
                            DMSO: 91 mg/mL (156.98 mM); Water: Insoluble; Warmed ethanol: 30 mg/mL (51.75 mM)
                         
                                                            
                            Identity
                            Confirmed by NMR/HPLC/MS.
                         
                                                                                                                                                            
                            Applications
                            CGI1746 is explored for its efficacy in blocking BTK activity, contributing to potential treatments for conditions like chronic lymphocytic leukemia.